What is DTIL's P/E ratio?

PRECISION BIOSCIENCES INC (DTIL) currently trades at a P/E ratio of 8.47.

PRECISION BIOSCIENCES INC reports a Return on Equity (ROE) of -58.46%.

What is DTIL's dividend yield?

PRECISION BIOSCIENCES INC offers a dividend yield of 0.00%.

What is DTIL's Deepscope Quality Score?

Deepscope rates DTIL's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy DTIL?

Deepscope's AI Timing Score for DTIL is 56 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does DTIL belong to?

PRECISION BIOSCIENCES INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

DTIL (NASDAQ) Stock Analysis | PRECISION BIOSCIENCES INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

DTIL

PRECISION BIOSCIENCES INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 88

USD 6.04

-0.28 (-4.43%) Day Change

Watchlist Portfolio Compare Chart

8.47

P/E

0.02

D/E

-58.5%

ROE

-30.9%

ROA

0.00%

Div Yield

-0.04

PEG

PRECISION BIOSCIENCES INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.04 Price -0.28 (-4.43%) Day Change	NEWS SCORE: 88

DTIL, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	88
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	6.04
PBV / Sector	2.14 / 4.48
Earning Per Share	-1.65

PE / Sector	8.47 / 16.68 GREAT
PEG or PE/Growth / Sector	-0.04 / 0.53
Average 1M Daily Value	2.29 M GREAT
Average 1W Daily Value	2.49 M GREAT

Timing Factors

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-98.70 / 450.37
NPM Average (%) / Sector	-158.99 / -1,506.30
NPM Change Average (%) / Sector	-402.82 / 4,941.44
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-30.92 / 30.83
ROA Average (%) / Sector	-28.22 / -347.12
ROA Change Average (%) / Sector	-200.95 / 5,126.35
ROE (%) / Sector	-58.46 / -3.04
ROE Average (%) / Sector	-121.22 / 40.76
ROE Change Average (%) / Sector	-127.45 / 2,110.63
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

Registration Details

Analyze Date	2026-06-04 09:24:23
Symbol	DTIL
Name	PRECISION BIOSCIENCES INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	25.80 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	163.07 / 8,483.11

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 302 East Pettigrew St., Durham, NC, United States, 27701

Phone: 919 314 5512

Website: https://precisionbiosciences.com

Employees: 66

Sector: Healthcare >> Biotechnology

Description: Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.